Genetic landscape of extreme responders with anaplastic oligodendroglioma

BACKGROUND: The NRG Oncology RTOG 9402 trial showed significant survival benefit in patients with 1p/19q co-deleted anaplastic oligodendrogliomas (AO) who received both radiation (RT) and chemotherapy (PCV regimen) versus RT alone. Substantial separation of the survival curves was only seen after 7....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Holdhoff, Matthias, Cairncross, Gregory J., Kollmeyer, Thomas M., Zhang, Ming, Zhang, Peixin, Mehta, Minesh P., Werner-Wasik, Maria, Souhami, Luis, Bahary, Jean-Paul, Kwok, Young, Hartford, Alan C., Chakravarti, Arnab, Yegnasubramanian, Srinivasan, Vogelstein, Bert, Papadopoulos, Nickolas, Kinzler, Kenneth, Jenkins, Robert B., Bettegowda, Chetan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2017
Pynciau:
Priority Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482595/
https://ncbi.nlm.nih.gov/pubmed/28388591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16773
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg